[Information] Boston Scientific $ 415 million acquisition of Bayer intervention equipment sector According fullmetal alchemist wigs to American healthcare information website FierceMedicalDevices reports, the leading US medical device manufacturer Boston Scientific (Boston Scientific) on Thursday (May 15) announced that it would buy $ 415 million of well-known pharmaceutical companies Bayer (Bayer) intervention Equipment Operations to strengthen Boston Scientific development and production capabilities in the field of peripheral vascular disease treatment equipment. Boston Scientific acquired the products, including Bayer interventional device business sector has developed AngioJet venous thrombectomy system, Fetch 2 Jetstream suction catheter system and within coronary plaque excision systems. Boston Scientific CEO Ma Hongming (Mike Mahoney) said in a statement: 'The new technology will help doctors who save more lives we think through the deal, to patients suffering from peripheral vascular Cosplay Costumes disease-ridden for more than 27 million worldwide. provide better service. 'It is reported that the transaction is expected in the second half of this year, when Bayer darkstalkers wigs intervention equipment business will be integrated into Boston Scientific Peripheral Intervention among business units. The first quarter of this year, Boston Scientific Peripheral Intervention business revenue mew mew wigs amounted to $ 203 million. Boston Scientific said Bayer intervention equipment business in 2013 annual sales of $ 120 million, has 350 employees. From the perspective of Bayer, the equipment business will sell its intervention in order to strengthen Bayer's core competencies. Bayer CEO Olivier Brady Lookout (Olivier Brandicourt), said: 'With this sale, our healthcare sector will be able to focus more on technological innovation and market growth in radiology and medical treatment in the field of diabetes, in which aspect we have their own advantages. 'Prior to Bayer, a number of other pharmaceutical companies have by selling assets to enhance their core competitiveness. In fact, just recently the price of Bayer's $ 14.2 billion acquisition of Merck (Merck) 's Consumer Healthcare and non-prescription products. In April, GlaxoSmithKline (Glaxo), Eli Lilly (Eli Lilly) and Novartis (Novartis) three pharmaceutical hell girl wigs companies were three transactions, thus strengthening their already leading business kateky hitman reborn wigs strength. Industry pointed out that the acquisition of Boston Scientific activities, but also that the world's major pharmaceutical giants in the business transformation process, medical device manufacturers are playing an active role.